Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | MLYCD | O95822 | 14/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.41 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1938699 | 0.86 | CES1 (0.54) | CES1MLYCDTRPV1TLR7 | |
| SCHEMBL1398393 | 0.78 | CES1 (0.59) | CES1MLYCD | |
| SCHEMBL8745850 | 0.76 | PPARA (0.61) | CES1ALDH1A1TSHRHSD17B10 | |
| SCHEMBL7248002 | 0.74 | CES1 (0.67) | CES1MLYCD | |
| SCHEMBL591541 | 0.74 | CES1 (0.50) | CES1MLYCDTRPV1 | |
| SCHEMBL8848226 | 0.74 | ALOX15 (0.58) | CES1MLYCDALDH1A1TSHR | |
| SCHEMBL9541163 | 0.74 | ELANE (0.56) | CES1MLYCDALDH1A1HSD17B10 | |
| SCHEMBL29177238 | 0.74 | KIF11 (0.56) | CES1MLYCDALDH1A1TRPV1 | |
| SCHEMBL17216 | 0.74 | CES1 (0.60) | CES1MLYCDTRPV1 | |
| SCHEMBL28130461 | 0.74 | CES1 (0.60) | CES1MLYCDTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-02-22 | — | — | US | disclosed |
| EP-1671941-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | Nissan Chemical Industries, Ltd. (JP) | 2006-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | L3MBTL1, L3MBTL3, L3MBTL4 | CES1 823/4885MLYCD 2468/4885ALDH1A1 888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.